Michael White (@MikeWhiteMD)

Michael White @MikeWhiteMD Jul 29, 2024

Apply for @MDAndersonNews T32 Research Fellowship "Training of Academic Surgical Oncologists" by Aug. 31! Gain research skills to be an independent surgical investigator in clinical, translational, and lab-based oncology research. Learn more @ bit.ly/3LG3G7l

Michael White @MikeWhiteMD Jun 15, 2022

Thrilled to share our work exploring the role of androgens modulating response to BRAF/MEK inhibition. Truly a team effort across @MDAndersonNews and beyond @Moran_Lab! More to come on the role of androgens across cancer types!!! nature.com/articles/s4158…

www.nature.com Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy Nature - Treatment with neoadjuvant BRAF/MEK-targeted therapy results in higher rates of major pathological response in female compared with male patients with melanoma, and pharmacological...

Michael White @MikeWhiteMD Jun 6, 2022

Fantastic presentation by @NassifElise outlining work at @MDAndersonNews as we begin to understand the link between the gut microbiome, tumor immune environment, and response to immunotherapy. @JenWargoMD @CrisyRoland @emilykeungMD #ASCO2022

Michael White @MikeWhiteMD Mar 10, 2022

Great talk at the immunotherapy hub by @anaikothari reviewing basal cell carcinoma. An important disease for surgical oncologists with exciting therapy options for metastatic disease. #SSO2022.

Michael White @MikeWhiteMD Mar 29, 2019

Very excited to see 🇺🇸 and 🇫🇷 debate the role of HIPEC in the management of peritoneal CRC (who needs soccer when you have cyroreductive surgery?!)

Michael White

Latest posts 5